205 related articles for article (PubMed ID: 21734055)
1. Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.
O'Brien KB; Schultz-Cherry S; Knoll LJ
J Virol; 2011 Sep; 85(17):8680-8. PubMed ID: 21734055
[TBL] [Abstract][Full Text] [Related]
2. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.
Van Hoeven N; Belser JA; Szretter KJ; Zeng H; Staeheli P; Swayne DE; Katz JM; Tumpey TM
J Virol; 2009 Apr; 83(7):2851-61. PubMed ID: 19144714
[TBL] [Abstract][Full Text] [Related]
4. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.
Cilloniz C; Pantin-Jackwood MJ; Ni C; Goodman AG; Peng X; Proll SC; Carter VS; Rosenzweig ER; Szretter KJ; Katz JM; Korth MJ; Swayne DE; Tumpey TM; Katze MG
J Virol; 2010 Aug; 84(15):7613-24. PubMed ID: 20504916
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.
Wu J; Zhang F; Fang F; Chang H; Wang F; Yang Z; Sun B; Chen Z
Vaccine; 2010 Mar; 28(15):2775-81. PubMed ID: 20117261
[TBL] [Abstract][Full Text] [Related]
6. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
[TBL] [Abstract][Full Text] [Related]
8. C5aR1 Activation Drives Early IFN-γ Production to Control Experimental
Briukhovetska D; Ohm B; Mey FT; Aliberti J; Kleingarn M; Huber-Lang M; Karsten CM; Köhl J
Front Immunol; 2020; 11():1397. PubMed ID: 32733463
[No Abstract] [Full Text] [Related]
9. Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
Hatta Y; Hershberger K; Shinya K; Proll SC; Dubielzig RR; Hatta M; Katze MG; Kawaoka Y; Suresh M
PLoS Pathog; 2010 Oct; 6(10):e1001139. PubMed ID: 20949022
[TBL] [Abstract][Full Text] [Related]
10. H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load.
Boon AC; Finkelstein D; Zheng M; Liao G; Allard J; Klumpp K; Webster R; Peltz G; Webby RJ
mBio; 2011; 2(5):. PubMed ID: 21896679
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
12. α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice.
Li K; Luo J; Wang C; He H
Vaccine; 2011 Oct; 29(44):7711-7. PubMed ID: 21839133
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.
Sawai T; Itoh Y; Ozaki H; Isoda N; Okamoto K; Kashima Y; Kawaoka Y; Takeuchi Y; Kida H; Ogasawara K
Immunology; 2008 Jun; 124(2):155-65. PubMed ID: 18205793
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration routes of vaccines.
Kashima Y; Ikeda M; Itoh Y; Sakoda Y; Nagata T; Miyake T; Soda K; Ozaki H; Nakayama M; Shibuya H; Okamatsu M; Ishigaki H; Ishida H; Sawai T; Kawaoka Y; Kida H; Ogasawara K
Vaccine; 2009 Dec; 27(52):7402-8. PubMed ID: 19747993
[TBL] [Abstract][Full Text] [Related]
16. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
17. Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.
Leymarie O; Jouvion G; Hervé PL; Chevalier C; Lorin V; Lecardonnel J; Da Costa B; Delmas B; Escriou N; Le Goffic R
PLoS One; 2013; 8(3):e57894. PubMed ID: 23469251
[TBL] [Abstract][Full Text] [Related]
18. Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice.
Leung YHC; Nicholls JM; Ho CK; Sia SF; Mok CKP; Valkenburg SA; Cheung P; Hui KPY; Chan RWY; Guan Y; Akira S; Peiris JSM
J Gen Virol; 2014 Sep; 95(Pt 9):1870-1879. PubMed ID: 24878639
[TBL] [Abstract][Full Text] [Related]
19. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
20. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
Kingstad-Bakke B; Kamlangdee A; Osorio JE
Vaccine; 2015 Sep; 33(39):5155-62. PubMed ID: 26271828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
